Xiangxue Pharmaceutical Co.,Ltd.

SZSE:300147.SZ

5.12 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 2,299.2882,187.072,970.5763,072.0912,786.22,504.2522,187.3171,862.0881,464.6051,523.981,261.115801.02616.09513.384378.633294.809258.308
Cost of Revenue 1,509.5211,644.5572,191.2952,079.5241,905.3971,591.1121,542.0671,274.021839.083888.856742.584417.531327.169271.368184.402141.746136.594
Gross Profit 789.766542.513779.281992.566880.803913.14645.25588.067625.522635.124518.531383.489288.921242.016194.232153.063121.713
Gross Profit Ratio 0.3430.2480.2620.3230.3160.3650.2950.3160.4270.4170.4110.4790.4690.4710.5130.5190.471
Reseach & Development Expenses 89.75694.79390.60466.9961.26838.67140.04833.28845.60350.76231.60325.65519.70915.509000
General & Administrative Expenses 64.57288.104105.96491.35563.57666.48853.11644.61731.03432.79528.52422.4416.51413.43839.52129.19825.996
Selling & Marketing Expenses 336.367333.141381.617339.038395.321373.306308.114251.072217.335202.949158.663131.721109.49882.76578.3174.8354.677
SG&A 400.939421.245487.581430.393458.897439.794361.23295.689248.369235.744187.187154.161126.01296.203117.831104.02880.673
Other Expenses -56.235172.82156.003130.891144.173-14.02220.34955.82131.95417.67817.3223.8113.5521.2080.589166.636-0.764
Operating Expenses 652.74688.858734.187628.275664.338619.513490.952454.053390.373375.63284.086235.299185.595138.956121.054106.30882.823
Operating Income -332.716-152.93534.986327.973275.212126.026105.5559.21185.565206.942177.334125.68897.19486.84460.10735.32135.778
Operating Income Ratio -0.145-0.070.0120.1070.0990.050.0480.0320.1270.1360.1410.1570.1580.1690.1590.120.139
Total Other Income Expenses Net -56.235-361.781-670.761-161.834-158.135-14.02220.34955.38931.93717.65317.3223.8113.5521.2080.5895.356-0.764
Income Before Tax -388.951-514.716-635.775166.139117.077112.003125.899114.599217.502224.595194.656129.499100.74688.05160.69640.67735.015
Income Before Tax Ratio -0.169-0.235-0.2140.0540.0420.0450.0580.0620.1490.1470.1540.1620.1640.1720.160.1380.136
Income Tax Expense 12.795-6.79522.92224.341-9.05324.03313.77416.96215.8568.05123.56420.32615.86712.6368.6413.3993.32
Net Income -388.964-507.921-658.697141.797126.1356.43965.93966.024177.298196.796158.243107.16883.49774.19950.91735.95130.781
Net Income Ratio -0.169-0.232-0.2220.0460.0450.0230.030.0350.1210.1290.1250.1340.1360.1450.1340.1220.119
EPS -0.59-0.77-10.220.190.090.10.10.280.320.330.180.140.160.130.090.078
EPS Diluted -0.59-0.77-10.220.190.090.10.10.280.320.330.180.140.160.130.090.078
EBITDA 263.03789.362184.899463.295389.99438.475424.505298.605374.648372.083311.87203.271144.866123.82187.807227.5553.701
EBITDA Ratio 0.1140.0410.0620.1510.140.1750.1940.160.2560.2440.2470.2540.2350.2410.2320.7720.208